SESSION 9: MDIs in Transition:
A Regulatory Roadmap to Market
Thursday • May 9, 2024 • 8:30–11:30 AM • Arizona Ballroom
Including
Explore with Experts Panel Discussion
Moderators: Ann Purrington and Nick Smalley, Kindeva Drug Delivery
FDA Perspectives on Scientific and Regulatory Considerations for MDIs Transitioning to a Low Global Warming Potential Propellant
Bryan Newman and Markham Luke
U.S. Food & Drug Administration
U.S. Food & Drug Administration
Generic Symbicort: Navigating the Technical and Regulatory Hurdles for Budesonide / Formoterol Fumarate Pressurized Metered Dose Inhaler
Stephen Stein
Kindeva Drug Delivery
Kindeva Drug Delivery
A Regulatory Roadmap for the Transition to Low GWP pMDIs: A Proposal for Discussion
Richard Lostritto
Lostritto Consulting, LLC
Lostritto Consulting, LLC
EXPLORE WITH EXPERTS:
Ann Purrington and Nick Smalley, Kindeva Drug Delivery
Ann Purrington and Nick Smalley, Kindeva Drug Delivery
Panel: Elizabeth Bielski, Richard Lostritto, Markham Luke, Bryan Newman, Stephen Stein
Discover More